Core Laboratories Gains as 4Q View Looks Insulated from Tariffs

Dow Jones
2025/10/24
 

By Katherine Hamilton

 

Core Laboratories shares climbed after the energy-services company gave strong fourth-quarter guidance and said new tariff measures likely won't apply to most of its revenue sources.

The stock jumped 28%, to $16.36, on Thursday. Shares are still down 7% this year.

The company said it expects fourth-quarter revenue to be $132 million to $136 million, which would be ahead of the $128.6 million analysts were projecting, according to FactSet. Earnings per share are guided to be 18 cents to 22 cents, while analysts were forecasting 19 cents.

Core Laboratories believes the tariffs under consideration won't apply to the vast majority of its service revenue and product sales, it said. Services account for more than 75% of the Houston company's total revenue and currently aren't subject to tariffs.

Product sales have made up less than a quarter of total revenue and are primarily manufactured in the U.S. Tariffs on exported goods wouldn't apply to about half of those product sales, as they are consumed in the U.S. drilling and completion markets.

While tariff headwinds are contributing to market volatility and lower commodity prices right now, longer-term crude oil demand remains intact despite tariffs, the company said.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

October 23, 2025 12:18 ET (16:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10